Results 181 to 190 of about 19,083 (252)

Dose reduction and discontinuation of non-tumor necrosis factor (TNF) biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) for people with rheumatoid arthritis in remission or low disease activity. [PDF]

Cochrane Database Syst Rev
Li YJ, Lopez-Olivo MA, Geng Y, Tayar JH, Suarez-Almazor ME.   +4 more
europepmc   +1 more source

Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort. [PDF]

Clin Rheumatol
Etani Y, Okita Y, Tsujimoto K, Noguchi T, Murata K, Fujii T, Shirasugi I, Yamashita M, Nagai K, Yoshikawa A, Hashimoto M, Okano T, Nozaki Y, Itami T, Son Y, Makino H, Yamamoto W, Kumanogoh A, Okada S, Nakata K, Ebina K.   +20 more
europepmc   +1 more source

Impact of the 2018 Japan Floods on Methotrexate and Antirheumatic Drug Prescriptions: A Longitudinal Analysis of the Japanese National Database. [PDF]

JMA J
Kidoguchi G, Yoshida S, Sugimoto T, Hirata S, Matsumoto M.   +4 more
europepmc   +1 more source

Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the 'AIRE' multicentre study. [PDF]

RMD Open
Paci V, Zabotti A, Fontanarosa A, Celletti E, Lopalco G, Foti R, Di Zio R, Perrotta FM, Di Penta M, Visalli E, Agostinelli A, Marchionni G, Ramonda R, Foti R, Iannone F, Quartuccio L, Gesuita R, Moroncini G, Luchetti Gentiloni MM, Lubrano E.   +19 more
europepmc   +1 more source

INDOMETHACIN: A NEW ANTIRHEUMATIC AGENT.

Minnesota medicine, 1996
P J, BILKA, F, WOLLHEIM, R C, WILLIAMS
openaire   +1 more source

Altered Lipid Metabolism in Psoriatic Arthritis: A Comprehensive Review. [PDF]

Metabolites
Popova-Belova S, Geneva-Popova M, Stoilova S, Popova V, Nikolov G, Nikolov D.   +5 more
europepmc   +1 more source

Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis. [PDF]

RMD Open
Ahmadzay ZF, Ørnbjerg LM, Østergaard M, Jensen KY, Jørgensen JB, Heberg J, Loft AG, Michelsen B, Jones GT, Hellamand P, Møller-Bisgaard S, Shoae Kazemi M, Karimi Reikandeh P, Závada J, Horák P, Bernardes M, Vieira-Sousa E, Castrejón I, Otero-Varela L, Codreanu C, Kuusalo L, Rantalaiho V, Regierer AC, Reich A, Möller B, Micheroli R, Mielnik P, Provan SA, Lass K, Vorobjov S, Rotar Z, Pirkmajer KP, Iannone F, Conti F, Gudbjornsson B, Di Giuseppe D, van de Sande M, Macfarlane GJ, Yarkan-Tuğsal H, Glintborg B, Hetland ML.   +40 more
europepmc   +1 more source

Biologic Therapy Is Associated with Faster Bone Union After the Sauvé-Kapandji Procedure in Patients with Rheumatoid Arthritis. [PDF]

Rheumatol Ther
Okabe H, Maeda K, Yamashita Y, Zenitani A, Nishizawa T, Yukawa M, Nishimura R, Bo H, Miyawaki T, Saito M.   +9 more
europepmc   +1 more source

Seropositive rheumatoid arthritis with concomitant MRI confirmed sacroiliitis in an 18-year-old Saudi female: A case report of diagnostic and therapeutic challenges. [PDF]

Medicine (Baltimore)
Alenzi F, AlYamini S.
europepmc   +1 more source

2. Antirheumatic Agents, 1) Non-biologic Agents

Nihon Naika Gakkai Zasshi, 2012
openaire   +2 more sources